<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T02:45:31Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/164842" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/164842</identifier><datestamp>2025-12-05T14:32:04Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478923</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Neutral and ionic platinum compounds containing a cyclometalated chiral primary amine: Synthesis, antitumor activity, DNA interaction and topoisomerase I - cathepsin B inhibition</dc:title>
   <dc:creator>Albert Mach, Joan</dc:creator>
   <dc:creator>Bosque Pueyo, Ramón</dc:creator>
   <dc:creator>Crespo, M.</dc:creator>
   <dc:creator>Granell Sanvicente, Jaime Ramón</dc:creator>
   <dc:creator>López Martínez, Ma. Concepción</dc:creator>
   <dc:creator>Martín, Raquel</dc:creator>
   <dc:creator>González, A.</dc:creator>
   <dc:creator>Jayaraman, A.</dc:creator>
   <dc:creator>Quirante Serrano, Josefina</dc:creator>
   <dc:creator>Calvis, Carme</dc:creator>
   <dc:creator>Badía Palacín, Josefa</dc:creator>
   <dc:creator>Baldomà Llavinés, Laura</dc:creator>
   <dc:creator>Font Bardia, Ma. Mercedes</dc:creator>
   <dc:creator>Cascante i Serratosa, Marta</dc:creator>
   <dc:creator>Messeguer i Peypoch, Ramon</dc:creator>
   <dc:subject>Platí</dc:subject>
   <dc:subject>Càncer</dc:subject>
   <dc:subject>Platinum</dc:subject>
   <dc:subject>Cancer</dc:subject>
   <dcterms:abstract>The synthesis and preliminary biological evaluation of neutral and cationic platinum derivatives of chiral 1-(1-naphthyl)ethylamine are reported, namely cycloplatinated neutral complexes [PtCl{(R or S)-NH(2)CH(CH(3))C(10)H(6)}(L)] [L = SOMe(2) ( 1-R or 1-S ), L = PPh(3) (2-R or 2-S), L = P(4-FC(6)H(4))(3) (3-R), L = P(CH(2))(3)N(3)(CH(2))(3) (4-R)], cycloplatinated cationic complexes [Pt{(R)-NH(2)CH(CH(3))C(10)H(6)}{L}]Cl [L = Ph(2)PCH(2)CH(2)PPh(2) (5-R), L = (C(6)F(5))(2)PCH(2)CH(2)P(C(6)F(5))(2) (6-R)] and the Pt(ii) coordination compound trans-[PtCl(2){(R)-NH(2)CH(CH(3))C(10)H(6)}(2)] (7-R). The X-ray molecular structure of 7-R is reported. The cytotoxic activity against a panel of human adenocarcinoma cell lines (A-549 lung, MDA-MB-231 and MCF-7 breast, and HCT-116 colon), cell cycle arrest and apoptosis, DNA interaction, topoisomerase I and cathepsin B inhibition, and Pt cell uptake of the studied compounds are presented. Remarkable cytotoxicity was observed for most of the synthesized Pt(ii) compounds regardless of (i) the absolute configuration R or S, and (ii) the coordinated/cyclometallated (neutral or cationic) nature of the complexes. The most potent compound 2-R (IC(50) = 270 nM) showed a 148-fold increase in potency with regard to cisplatin in HCT-116 colon cancer cells. Preliminary biological results point out to different biomolecular targets for the investigated compounds. Neutral cyclometallated complexes 1-R and 2-R, modify the DNA migration as cisplatin, cationic platinacycle 5-R was able to inhibit topoisomerase I-promoted DNA supercoiling, and Pt(ii) coordination compound 7-R turned out to be the most potent inhibitor of cathepsin B. Induction of G-1 phase ( 2-R and 5-R ), and S and G-2 phases (6-R) arrests are related to the antiproliferative activity of some representative compounds upon A-549 cells. Induction of apoptosis is also observed for 2-R and 6-R.</dcterms:abstract>
   <dcterms:issued>2020-06-08T18:20:00Z</dcterms:issued>
   <dcterms:issued>2020-06-08T18:20:00Z</dcterms:issued>
   <dcterms:issued>2015</dcterms:issued>
   <dcterms:issued>2020-06-08T18:20:00Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1039/c5dt01713k</dc:relation>
   <dc:relation>Dalton Transactions, 2015, vol. 44, num. 30, p. 13602-13614</dc:relation>
   <dc:relation>https://doi.org/10.1039/c5dt01713k</dc:relation>
   <dc:rights>(c) Albert Mach, Joan et al., 2015</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Royal Society of Chemistry</dc:publisher>
   <dc:source>Articles publicats en revistes (Mineralogia, Petrologia i Geologia Aplicada)</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>